Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-24

Clinical Trial Update: Transtympanic Gentamicin vs. Steroids in Refractory Meniere's Disease [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial comparing transtympanic gentamicin versus steroids for refractory Meniere's disease has completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gentamicin (gentamicin)
  • steroids

Snippet

Sponsor: Imperial College London | Conditions: Meniere's Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-10-24